Navigation Links
Prism glasses expand the view for patients with hemianopia
Date:5/12/2008

Boston, MA Innovative prism glasses can significantly improve the vision and the daily lives of patients with hemianopia, a condition that blinds half the visual field in both eyes. The peripheral prism glasses, which were invented by Dr. Eli Peli, a Senior Scientist at Schepens Eye Research Institute, were evaluated in the first community-based multi-center trial of such a device, which is published in the May issue of the Archives of Ophthalmology. The study was coordinated by Dr. Alex Bowers, a Senior Scientific Associate at the Institute.

This is the first real breakthrough in the rehabilitation of patients with this condition, says Peli, a world-renowned low vision expert, the Moakley Scholar in Aging Eye Research at Schepens and a Professor of Ophthalmology at Harvard Medical School. Peli had searched for a solution for his hemianopia patients for many years before designing the peripheral prism glasses, creating a prototype in his laboratory.

More than a million Americans suffer from hemianopia, which blinds the vision in one half of the visual field in both eyes, resulting from damage to the optic pathways in the brain. Most commonly caused by strokes, it can also be the result of brain damage from tumors or trauma. A patient with this condition may be unaware of what he or she cannot see and frequently bumps into walls, trips over objects or walks into people on the side where the visual field is missing.

Pelis goal was to find a way to expand the visual field. He did this by attaching small, specially designed high power prisms on the top and bottom of one spectacle lens, leaving the center of the lens untouched. The prisms pull in images missing from the visual field above and below the line of sight on the side of the vision loss, and alert the patient to the presence of a potential obstacle or hazard. The patient can then move his/her head and eyes to examine the prism-captured image directly through the clear center of
'/>"/>

Contact: Patti Jacobs
pjacobs12@comcast.net
617-864-2712
Schepens Eye Research Institute
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. New Empire BlueCross BlueShield Prism Plans Offer Better Choice and Affordability for New York Small Group Market
2. Prism Pharmaceuticals Appoints Maurits Geerlings Vice President of Business Development
3. Study: Kids think eyeglasses make other kids look smart
4. Mythbusted -- people who wear glasses arent geeks
5. Eyeglasses Upgrade Helps Elderly Battle Depression
6. Wyle Targets New Customers for Expanded Human Health and Performance Capabilities and Services
7. New Payroll Service Expands Selling Power and Service Capability of Employee Benefits Brokers
8. American Pain Societys low back guideline expanded to cover interventional procedures
9. Tobacco Quit Line Expands Services for Pregnant Women Who Smoke
10. Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA
11. MSDSonline Expands On-Demand Training Offering

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/7/2009)...d for Life Action endorses a key vote today on the...Dahlkemper-Lipinski-Smith Amendment, an Amendment ...on in health care reform. ,, Americans United for ...t said, "Americans United for Life Action strongly...mper-Lipinski-Smith Amendment to prohibit abortion...
(Date:11/7/2009)...uth will rebel, expert says , , SATURDAY, ...o behave badly if their parents expect them to, a ...hey are simply being realistic might actually cont...hanan, a psychology professor at Wake Forest Unive...sity news release. "Negative expectations on the p...
(Date:11/7/2009)...-25th marked the 12th annual tournament bringing t...e against pediatric cancer. Stephen Updegraff, MD...r many years. , St. Peter...d of October 23-25 marked the 12th annual tournam...ting the battle against pediatric cancer– To...
(Date:11/7/2009)...quo;sweatox’ or ‘Boytox’, the ne...i-ageing jab ‘Breastox’ – or bre...colletage, can reduce the appearance of wrinkles a...sts, leaving smoother, younger-looking skin. , ...Transform, the UK’s largest group of cosmet...
(Date:11/6/2009)...ER, Nov. 6 /PRNewswire-FirstCall/ - Cardiome Pharm...d that it will report financial results for the th...g of Monday, November 9, 2009. Cardiome will hold ...n (6:00am Pacific) on that day to discuss the resu... 416-695-7806 or 888-789-9572 and reference confer...
Breaking Medicine News(10 mins):Health News:Americans United for Life Action Endorses a Vote for the Stupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Amendment and Sends Score Letter to House Members 2Health News:Bad-Behaving Teens May Be Living Up to Expectations 2Health News:Updegraff Vision Proudly Supports The Pediatric Cancer Foundation 2Health News:Updegraff Vision Proudly Supports The Pediatric Cancer Foundation 3Health News:UK Boobs Get a Boost with 'Breastox' 2Health News:Cardiome to Release Third Quarter Results 2Health News:Cardiome to Release Third Quarter Results 3
...A new study has found that single tablets containi...olling increasing blood pressure in people with e...al study named ACCOMPLISH (Avoiding Cardiovascular...niversity of Michigan Medical School. As p...
...Stanford University School of Medicine researchers...of the body's immune system known as troublemaker...ficial for metabolism. The new finding is ...eputation for being the bad guys. We have found th...
...The lives of laborers begin from mines and end wit...desh. Forced to work in illegal stone quarries b...o silica dust puts the laborers at high risk of ge...villages of Madhya Pradesh's Morena district. ...
...A new study has found that apart from using mobile...f passengers in a vehicle could increase the risk...itute for International Health, was intended to de...und that passengers also contribute to road accide...
...Addressing the concerns of developing countries li...World Health Organization (WHO), has promised eff...istribution of pandemic influenza vaccines at affo... A resolution on those lines is being adopted by t...
...One almost freezes in horror watching the ghastly ...ocks, on the ground then, covering her head as sto...shed with a concrete block, blood oozes from her h...ad, 17, was to love a boy from another religion. S...
Other Medicine News:Health News:Single-tablet With Two Drugs may Help Control High BP Better 2Health News:Macrophages may Help Prevent Obesity 2Health News:Miners in Madhya Pradesh at High Risk of Developing TB 2Health News:Not Only Mobile Phones, Even Passengers can Increase the Risk of Road Accidents 2Health News:WHO Announces Deal on Sharing Bird Flu Virus 2Health News:Women in Iraq More Unsafe Than Ever 2
(Date:11/6/2009)... -- Philips Respironics applauds the efforts of th... to raise awareness about an important public heal... release of the first-ever government study to mon...s a milestone in quantifying the size and scope of...stry leader and sleep therapy manufacturer, Philip...
(Date:11/6/2009).../ -- Cyberonics, Inc. (Nasdaq: CYBX ) today annou...s for the second quarter ended October 23, 2009 of...y, November 18, 2009 at 5:00 PM EST. The company ...sults on Thursday, November 19, 2009 at 9:00 AM ES... Conference Call Instructions ,, To listen to...
(Date:11/6/2009)... , - Trial Will Compare NXL103 With Leadi...-Resistant Staphylococcus Aureus (MRSA) Infections...ompany focused on the discovery and,development of...icant global,problem of microbial resistance, anno...ial NXL103 (flopristin/linopristin), has started a...
Breaking Medicine Technology:Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Angiotechs Licensee Cook Medical Announces CE Mark Approval and European Launch of the Zilver 28R 29 PTX 28R 29 Stent 13489 1Angiotechs Licensee Cook Medical Announces CE Mark Approval and European Launch of the Zilver 28R 29 PTX 28R 29 Stent 13489 2Angiotechs Licensee Cook Medical Announces CE Mark Approval and European Launch of the Zilver 28R 29 PTX 28R 29 Stent 13489 3Angiotechs Licensee Cook Medical Announces CE Mark Approval and European Launch of the Zilver 28R 29 PTX 28R 29 Stent 13489 4Angiotechs Licensee Cook Medical Announces CE Mark Approval and European Launch of the Zilver 28R 29 PTX 28R 29 Stent 13489 5Angiotechs Licensee Cook Medical Announces CE Mark Approval and European Launch of the Zilver 28R 29 PTX 28R 29 Stent 13489 6Angiotechs Licensee Cook Medical Announces CE Mark Approval and European Launch of the Zilver 28R 29 PTX 28R 29 Stent 13489 7Angiotechs Licensee Cook Medical Announces CE Mark Approval and European Launch of the Zilver 28R 29 PTX 28R 29 Stent 13489 8DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 1DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 2DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 3DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 4DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 5DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 6DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 7DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 8DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 9DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 10DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 11DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 12DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 13Rockport Healthcare Group Continues to Grow Coverage Area With New Work Comp Network Certification in Georgia 54149 1Rockport Healthcare Group Continues to Grow Coverage Area With New Work Comp Network Certification in Georgia 54149 2
...e many, clinical studies are few, NEW YORK, Aug. ...that a limited amount of clinical research exists,...r (OTC) anti-aging,products. The study is publishe...urgery Journal, the official peer-reviewed journal...gery (ASAPS). OTC anti-aging products represent a...
...tional Stem,Cell Holding, Inc. (OTC: NHGI.PK), tod...y, and Jacob Cohen, have discovered biomaterial de...s to promote tissue repair in,various wound care a...ced that while using its,proprietary embryonic ste...,group of biomaterials that in preclinical studies...
Other Medicine Technology:OTC Anti-Aging Products: Hype or Hope? 2National Stem Cell Holding, Inc. Discovers Non-Embryonic Biomaterials that Promote Tissue Repair 2National Stem Cell Holding, Inc. Discovers Non-Embryonic Biomaterials that Promote Tissue Repair 3
...AREDS formula is the one and only vitamin and mine...nstitute's age-related eye study (AREDS) 10-year t...cal Age-Related Eye Disease Study (AREDS) by the N...Institutes of Health) showed that a unique vitamin...
Ocuvite® Eye Vitamins and Mineral Supplement
...aps, the patented next-generation dietary suppleme...systemically address the root inflammatory cause a... peer-reviewed literature that these specific nutr...ther affected parts of the body, such as mucous me...
...the industry-leading portal to QC information, pro... way to access their quality control data and othe...b enables Bio-Rad customers to access on-demand (I...s, as well as convenient online data entry and man...
Medicine Products: